Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial

Michelle L O'Donoghue, Ruchira Glaser, Philip E Aylward, Matthew A Cavender, Adam Crisp, Keith A A Fox, Ian Laws, Jose L Lopez-Sendon, P Gabriel Steg, Pierre Theroux, Marc S Sabatine, David A Morrow

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences